Predictive factors for hyperglycaemic progression in patients with schizophrenia or bipolar disorder.

Background: Patients with schizophrenia or bipolar disorder have a high risk of developing type 2 diabetes.

Aims: To identify predictive factors for hyperglycaemic progression in individuals with schizophrenia or bipolar disorder and to determine whether hyperglycaemic progression rates differ among antipsychotics in regular clinical practice.

Method: We recruited 1166 patients who initially had normal or prediabetic glucose levels for a nationwide, multisite, l-year prospective cohort study to determine predictive factors for hyperglycaemic progression.